As widely expected by the pharmaceutical industry, seven pharmaceutical companies are releasing biosimilars of AbbVie's Humira. Boehringer Ingelheim's Cyltezo (adalimumab-adbm), an interchangeable ...
SIMLANDI is the first citrate-free, high-concentration biosimilar to be designated interchangeable to Humira in the U.S. SIMLANDI is the first biosimilar approval under the strategic partnership ...
Cimzia and Humira are both FDA-approved biologics that treat inflammatory conditions by preventing the immune system from attacking healthy cells. While both medications can cause injection site ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results